NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
Clinical Trial
TailorMed and Flatiron Health Partner to Expand Medication Access and Support Across Oncology Care
Collaboration brings end-to-end medication support to Flatiron's network, helping community oncology practices connect patients to the resources they need to...
CMS EXPOSED: The “Workaround Doctrine” – How Matt Zorn’s Legal CMS Hemp Strategy Undermines the FDA
Matthew C. Zorn previously argued that federal regulators determine "accepted medical use" through the FDA approval framework. Today, he appears...
VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support
VisioCore Vision Support Supplement Ingredients, Lutein and Zeaxanthin Formula, Pricing, Official Website Access, and 60-Day Guarantee Explained for 2026Aurora, CO,...
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage...
Celcuity’s Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
Detailed data for the gedatolisib triplet and doublet regimens will be presented at a late-breaking abstract oral session at the...
MIB Agents Marks 10th Anniversary with National Day of Giving to Accelerate Osteosarcoma Breakthroughs
National nonprofit marks milestone with call to action to expand impact nationwide BARNARD, VT / ACCESS Newswire / May 1,...
Three Finalists Announced for the 2026 Bloom Burton Award
Recognizing the Year's Most Significant Contributions to Canada's Innovative Healthcare IndustryToronto, Ontario--(Newsfile Corp. - May 1, 2026) - Bloom Burton...
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports first quarter GAAP net loss...
Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer
Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical Center. MIAMI,...
Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distributionAdds Filament's extensive intellectual property portfolio, including...
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company...
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company...
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company...
Evotec Receives Grants to Advance Tuberculosis Treatment
Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testingNew...
CMS Is Quietly Pushing Unvalidated Hemp -Marijuana Products on America’s Elderly – and Calling It Healthcare
"Without clinical evidence, without public notice, and without congressional authorization, the federal government inserted psychoactive consumer products into Medicare -...
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven...
RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET
MOUNTAIN VIEW, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences...
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
Sangamo’s common stock to transition trading from The Nasdaq Capital Market to OTCQB Venture Market beginning May 5, 2026RICHMOND, Calif.,...
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA submission in Q4 2026...